Zobrazeno 1 - 10
of 234
pro vyhledávání: '"Buijsen, J"'
Autor:
van de Water, L.F., Kuijper, S.C., Henselmans, I., van Alphen, E.N., Kooij, E.S., Calff, M.M., Beerepoot, L.V., Buijsen, J., Eshuis, W.J., Geijsen, E.D., Havenith, S.H.C., Heesakkers, F.F.B.M., Mook, S., Muller, K., Post, H.C., Rütten, H., Slingerland, M., van Voorthuizen, T., van Laarhoven, H.W.M., Smets, E.M.A.
Publikováno v:
In eClinicalMedicine October 2023 64
Autor:
Rijkmans, E.C., van Triest, B., Nout, R.A., Kerkhof, E.M., Buijsen, J., Rozema, T., Franssen, J.H., Velema, L.A., Laman, M.S., Cats, A., Marijnen, C.A.M.
Publikováno v:
In Radiotherapy and Oncology March 2018 126(3):417-423
Publikováno v:
Systematic Botany, 2003 Jan 01. 28(1), 106-117.
Externí odkaz:
https://www.jstor.org/stable/3093941
Autor:
Versteijne, E., Dam, J.L. van, Suker, M., Janssen, Q.P., Groothuis, K., Akkermans-Vogelaar, J.M., Besselink, M.G., Bonsing, B.A., Buijsen, J., Busch, O.R., Creemers, G.J.M., Dam, R.M. van, Eskens, F.A.L.M., Festen, S., Groot, J.W.B. de, Koerkamp, B.G., Hingh, I.H. de, Homs, M.Y.V., Hooft, J.E. van, Kerver, E.D., Luelmo, S.A.C., Neelis, K.J., Nuyttens, J., Paardekooper, G.M.R.M., Patijn, G.A., Sangen, M.J.C. van der, Vos-Geelen, J. de, Wilmink, J.W., Zwinderman, A.H., Punt, C.J., Tienhoven, G. van, Eijck, C.H.J. van, Dutch Pancreatic Canc Grp
Publikováno v:
Journal of Clinical Oncology, 40(11), 1220-1230. American Society of Clinical Oncology
Versteijne, E, van Dam, J L, Suker, M, Janssen, Q P, Groothuis, K, Akkermans-Vogelaar, J M, Besselink, M G, Bonsing, B A, Buijsen, J, Busch, O R, Creemers, G-J M, van Dam, R M, Eskens, F A L M, Festen, S, de Groot, J W B, Groot Koerkamp, B, de Hingh, I H, Homs, M Y V, van Hooft, J E, Kerver, E D, Luelmo, S A C, Neelis, K J, Nuyttens, J, Paardekooper, G M R M, Patijn, G A, van der Sangen, M J C, de Vos-Geelen, J, Wilmink, J W, Zwinderman, A H, Punt, C J, van Tienhoven, G & van Eijck, C H J 2022, ' Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer : Long-Term Results of the Dutch Randomized PREOPANC Trial ', Journal of Clinical Oncology, vol. 40, no. 11, pp. 1220-1230 . https://doi.org/10.1200/JCO.21.02233
Journal of Clinical Oncology, 40(11), 1220-+. LIPPINCOTT WILLIAMS & WILKINS
Journal of clinical oncology, 40(11), 1220-1230. American Society of Clinical Oncology
Versteijne, E, van Dam, J L, Suker, M, Janssen, Q P, Groothuis, K, Akkermans-Vogelaar, J M, Besselink, M G, Bonsing, B A, Buijsen, J, Busch, O R, Creemers, G-J M, van Dam, R M, Eskens, F A L M, Festen, S, de Groot, J W B, Groot Koerkamp, B, de Hingh, I H, Homs, M Y V, van Hooft, J E, Kerver, E D, Luelmo, S A C, Neelis, K J, Nuyttens, J, Paardekooper, G M R M, Patijn, G A, van der Sangen, M J C, de Vos-Geelen, J, Wilmink, J W, Zwinderman, A H, Punt, C J, van Tienhoven, G & van Eijck, C H J 2022, ' Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer : Long-Term Results of the Dutch Randomized PREOPANC Trial ', Journal of Clinical Oncology, vol. 40, no. 11, pp. 1220-1230 . https://doi.org/10.1200/JCO.21.02233
Journal of Clinical Oncology, 40(11), 1220-+. LIPPINCOTT WILLIAMS & WILKINS
Journal of clinical oncology, 40(11), 1220-1230. American Society of Clinical Oncology
PURPOSE The benefit of neoadjuvant chemoradiotherapy in resectable and borderline resectable pancreatic cancer remains controversial. Initial results of the PREOPANC trial failed to demonstrate a statistically significant overall survival (OS) benefi
Autor:
Van De Voorde, L., Vanneste, B., Houben, R., Damen, P., van den Bogaard, J., Lammering, G., Dejong, K., de Vos-Geelen, J., Buijsen, J., Öllers, M., Berbée, M., Lambin, P.
Publikováno v:
In European Journal of Surgical Oncology February 2015 41(2):249-256
Autor:
van Rees, J.M., Krul, M.F., Kok, N.F.M., Grunhagen, D.J., Kok, E.N.D., Nierop, P.M.H., Havenga, K., Rutten, H., Burger, J.W.A., de Wilt, J.H.W., Hagendoorn, J., Peters, F.P., Buijsen, J., Tanis, P.J., Verhoef, C., Kuhlmann, K.F.D.
Publikováno v:
British Journal of Surgery. Wiley
Autor:
Luijten, J., Vissers, Pauline A.J., Brom, L., Bièvre, M. de, Buijsen, J., Rozema, T., Mohammad, N.H., Duijvendijk, P. van, Kouwenhoven, E.A., Eshuis, W.J., Rosman, C., Siersema, P.D., Laarhoven, H.W.M. van, Verhoeven, R.H.A., Nieuwenhuijzen, G.A., Westerman, M.J.
Publikováno v:
BMC Health Services Research, 22(1):527. BioMed Central
BMC health services research, 22(1):527. BioMed Central
BMC Health Services Research, 22
BMC Health Services Research, 22(1):527. BioMed Central Ltd
Luijten, J C H B M, Vissers, P A J, Brom, L, de Bièvre, M, Buijsen, J, Rozema, T, Mohammad, N H, van Duijvendijk, P, Kouwenhoven, E A, Eshuis, W J, Rosman, C, Siersema, P D, van Laarhoven, H W M, Verhoeven, R H A, Nieuwenhuijzen, G A P & Westerman, M J 2022, ' Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study ', BMC Health Services Research, vol. 22, no. 1, 527 . https://doi.org/10.1186/s12913-022-07845-2
BMC Health Services Research, 22, 1
BMC health services research, 22(1):527. BioMed Central
BMC Health Services Research, 22
BMC Health Services Research, 22(1):527. BioMed Central Ltd
Luijten, J C H B M, Vissers, P A J, Brom, L, de Bièvre, M, Buijsen, J, Rozema, T, Mohammad, N H, van Duijvendijk, P, Kouwenhoven, E A, Eshuis, W J, Rosman, C, Siersema, P D, van Laarhoven, H W M, Verhoeven, R H A, Nieuwenhuijzen, G A P & Westerman, M J 2022, ' Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study ', BMC Health Services Research, vol. 22, no. 1, 527 . https://doi.org/10.1186/s12913-022-07845-2
BMC Health Services Research, 22, 1
Background Among esophagogastric cancer patients, the probability of having undergone treatment with curative intent has been shown to vary, depending on the hospital of diagnosis. However, little is known about the factors that contribute to this va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::117dd973d1ce278dc51ed328563ececf
https://research.vumc.nl/en/publications/93dc58ec-d63f-49d3-9298-4b8e5a00878f
https://research.vumc.nl/en/publications/93dc58ec-d63f-49d3-9298-4b8e5a00878f
Autor:
Bomhof-Roordink, H., Stiggelbout, A.M., Gartner, F.R., Portielje, J.E.A., Kroon, C.D. de, Peeters, K.C.M.J., Neelis, K.J., Dekker, J.W.T., Weijden, T. van der, Pieterse, A.H., Boer, S.M. de, Boersma, L.J., Huinink, D.T., Buijsen, J., Cloos-van Balen, M., Gelderblom, H., Leeuwen-Snoeks, L. van, Lips, I.M., Ramai, S.R.S., Roshani, H., Slingerland, M., Vanneste, B.G.L., Wiltink, L.M., iSHARE Study Grp
Publikováno v:
Patient Education and Counseling, 105(5), 1089-1100. Elsevier Ireland Ltd
Patient Education and Counseling, 105(5), 1089-1100. ELSEVIER IRELAND LTD
Patient Education and Counseling, 105(5), 1089-1100. ELSEVIER IRELAND LTD
Objectives: We have developed two Dutch questionnaires to assess the shared decision-making (SDM) process in oncology; the iSHAREpatient and iSHAREphysician. In this study, we aimed to determine: scores, construct validity, test-retest agreement (iSH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::912883ab9c78f09a164110dc95c96878
https://hdl.handle.net/1887/3515773
https://hdl.handle.net/1887/3515773
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Versteijne, E., Suker, M., Groothuis, K., Akkermans-Vogelaar, J.M., Besselink, M.G., Bonsing, B.A., Buijsen, J., Busch, O.R., Creemers, G.J.M., Dam, R.M. van, Eskens, F.A.L.M., Festen, S., Groot, J.W.B. de, Koerkamp, B.G., Hingh, I.H. de, Homs, M.Y.V., Hooft, J.E. van, Kerver, E.D., Luelmo, S.A.C., Neelis, K.J., Nuyttens, J., Paardekooper, G.M.R.M., Patijn, G.A., Sangen, M.J.C. van der, Vos-Geelen, J. de, Wilmink, J.W., Zwinderman, A.H., Punt, C.J., Eijck, C.H. van, Tienhoven, G. van, Dutch Pancreatic Canc Grp
Publikováno v:
Journal of Clinical Oncology, 38(16), 1763-1773. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 38(16), 1763-1773. American Society of Clinical Oncology
Journal of Clinical Oncology, 38(16), 1763-1773. American Society of Clinical Oncology
J Clin Oncol
Journal of clinical oncology, 38(16), 1763-1773. American Society of Clinical Oncology
Journal of Clinical Oncology, 38(16), 1763-1773. American Society of Clinical Oncology
J Clin Oncol
PURPOSE Preoperative chemoradiotherapy may improve the radical resection rate for resectable or borderline resectable pancreatic cancer, but the overall benefit is unproven. PATIENTS AND METHODS In this randomized phase III trial in 16 centers, patie